ucsf logo

Jill Goslinga, MD, MPH

Neuromuscular Medicine • Neurology
Neuromuscular Parnassus
415-353-2273
ucsf logo

Jill Goslinga, MD, MPH

Neuromuscular Medicine • Neurology
Neuromuscular Parnassus
415-353-2273

On this page

Education & training

Board certification

  • Neuromuscular Medicine, American Board of Psychiatry and Neurology
  • Psychiatry & Neurology, American Board of Psychiatry and Neurology

Fellowship

  • Neuromuscular Medicine, UCSF School of Medicine -GME

Residency

  • Neurology, UCSF School of Medicine -GME

Internship

  • Neurology, UCSF School of Medicine -GME

Degree

  • MD, Harvard Medical School

Academic title

  • Health Sciences Clinical Professor

My expertise

Locations

    My research

    Reviews

    Average rating

    5
    5 out of 5 Stars
    137 ratings
    About provider reviews

    Showing 1-6 of 35 reviews

    Sort by
    • 5 out of 5 Stars
      May 28, 2026

      There should be a higher rating called EXCELLENT. I would rank all questions as excellent

    • 5 out of 5 Stars
      May 19, 2026

      Dr. Goslinga is one of my favorite UCSF doctors.

    • 5 out of 5 Stars
      February 5, 2026

      Thank you for everything!!! Because of you I am not in a wheelchair

    • 5 out of 5 Stars
      February 3, 2026

      I have been a satisfied patient of Dr. Goslinga's for several years now. I always look forward to meeting with her.

    • 5 out of 5 Stars
      January 15, 2026

      It's always been a great experience

    • 5 out of 5 Stars
      November 10, 2025

      Good experience

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.